Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II (TUMOSTEO II)
Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II: Texture Analysis and Artificial Intelligence
研究概览
详细说明
Comparison of values relating to the texture parameters of tumors evaluated by MRI and ultra-high resolution CT between benign and malignant lesions using histological analysis as the standard of reference.
Comparison of the diagnostic performance of texture parameters derived from different MRI sequences and ultra-high resolution CT for musculoskeletal tumor characterization.
Evaluate the impact of ultra-high resolution with respect to standard resolution on CT images Comparison of the diagnostic performance of the texture parameters for the tumor on the diagnostic performance of texture analysis derived parameters for the characterization of musculoskeletal tumors.
Evaluate the effectiveness and accuracy of automatic artificial intelligence (AI) based tumor segmentation tools.
Evaluate the use of trabecular analysis on ultra-high resolution CT images for the evaluation of tumor-bone interfaces.
研究类型
注册 (预期的)
联系人和位置
学习联系方式
- 姓名:Pedro Gondim Teixieira, PhD
- 电话号码:+33 3 83 85 21 61
- 邮箱:p.teixeira@chru-nancy.fr
研究联系人备份
- 姓名:Gabriela Hossu, PhD
- 电话号码:+33 3 83 15 50 96
- 邮箱:g.hossu@chru-nancy.fr
学习地点
-
-
Lorraine
-
Nancy、Lorraine、法国、54000
- 招聘中
- CHU-Nancy
-
接触:
- Pedro Gondim Teixeira, Prof
- 电话号码:+33383852161
- 邮箱:p.teixeira@chru-nancy.fr
-
接触:
- Alain Blum, Prof
- 电话号码:+33383852161
- 邮箱:alain.blum@gmail.com
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- Patients suspected to have a bone or soft-tissue tumor referred for imaging for initial tumors characterization and staging.
Exclusion Criteria:
- Pregnancy
- Breast feeding patients
- Renal insufficiency
- Contra indications to MRI or CT
- Prior surgery or treatment to the evaluated lesion.
学习计划
研究是如何设计的?
设计细节
- 观测模型:队列
- 时间观点:预期
队列和干预
团体/队列 |
干预/治疗 |
---|---|
Soft-tissue tumors
Benign and malignant soft tissue masses
|
Medical imaging
其他名称:
|
Bone tumors
Benign and malignant bone focal bone lesions
|
Medical imaging
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Lesion benignancy or malignancy
大体时间:Performed up to 6 months after CT and Magnetic Resonance (MR) imaging
|
Histologic determination of lesion aggressiveness (benign versus malignant) on core biopsy material
|
Performed up to 6 months after CT and Magnetic Resonance (MR) imaging
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Sarcoma FNCLCC (fédération Nationale des Centres de Lutte Contre le Cancer) grade
大体时间:Performed up to 1 year after CT and MR imaging
|
Histologic grade of the sarcomas included in the study population with surgical resection material
|
Performed up to 1 year after CT and MR imaging
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
MR imaging的临床试验
-
University of CalgaryAlberta Heritage Foundation for Medical Research; Calgary Health Region完全的
-
French Cardiology SocietyInstitut National de la Santé Et de la Recherche Médicale, France完全的
-
Medical Centre LeeuwardenUniversity of Groningen; LIMIS Development招聘中
-
National Institute of Diabetes and Digestive and...招聘中
-
Rabin Medical CenterRambam Health Care Campus; Hillel Yaffe Medical Center; US Department of Veterans Affairs; Assaf-Harofeh... 和其他合作者完全的
-
National Cancer Institute (NCI)招聘中
-
Bezmialem Vakif UniversityMuğla Sıtkı Koçman University; The Scientific and Technological Research Council of Turkey; Balikli...主动,不招人